Initial high-efficacy disease-modifying therapy in multiple sclerosisMathias Due Buron, Melinda Magyari, Thor Ameri Chalmer et al.|Neurology|2020Cited by 160
Comparative effectiveness of teriflunomide and dimethyl fumarateMathias Due Buron, Melinda Magyari, Thor Ameri Chalmer et al.|Neurology|2019Cited by 45
Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoderShuo Liu, Björn W. Schuller, Judith Dineley et al.|Pattern Recognition|2021Cited by 37
Late-onset MS is associated with an increased rate of reaching disability milestonesMads Albrecht Andersen, Melinda Magyari, Mathias Due Buron|Journal of Neurology|2021Cited by 28
Clinically stable disease is associated with a lower risk of both income loss and disability pension for patients with multiple sclerosisThor Ameri Chalmer, Melinda Magyari, Mathias Due Buron et al.|Journal of Neurology Neurosurgery & Psychiatry|2019Cited by 20